Literature DB >> 9524566

P53 tumour suppressor gene and germ cell neoplasia.

S G Lutzker1.   

Abstract

P53 tumour suppressor gene mutations occur in approximately 50% of common solid tumours such as breast, colon and lung. In contrast, p53 gene mutations occur infrequently (< 3%) in germ cell tumours, even though p53 protein is expressed at high levels in the vast majority of tumour samples. P53-regulated genes are not correspondingly over-expressed in germ cell tumour samples and cell lines, indicating that p53 functions poorly as a transcription factor in this tumour type. High levels of wild-type p53 may contribute, in part, to the chemosensitivity of germ cell tumours.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9524566     DOI: 10.1111/j.1699-0463.1998.tb01323.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

Review 1.  Testicular germ cell tumor genomics.

Authors:  Solomon L Woldu; James F Amatruda; Aditya Bagrodia
Journal:  Curr Opin Urol       Date:  2017-01       Impact factor: 2.309

2.  MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue.

Authors:  Z Bing; S R Master; J W Tobias; D A Baldwin; X W Xu; J E Tomaszewski
Journal:  Virchows Arch       Date:  2012-10-14       Impact factor: 4.064

3.  A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection.

Authors:  Jorge Zeron-Medina; Xuting Wang; Emmanouela Repapi; Michelle R Campbell; Dan Su; Francesc Castro-Giner; Benjamin Davies; Elisabeth F P Peterse; Natalia Sacilotto; Graeme J Walker; Tamara Terzian; Ian P Tomlinson; Neil F Box; Nicolai Meinshausen; Sarah De Val; Douglas A Bell; Gareth L Bond
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

4.  p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.

Authors:  Matthias Gutekunst; Moshe Oren; Andrea Weilbacher; Michael A Dengler; Christiane Markwardt; Jürgen Thomale; Walter E Aulitzky; Heiko van der Kuip
Journal:  PLoS One       Date:  2011-04-21       Impact factor: 3.240

5.  MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors.

Authors:  Matteo Rossi; David Colecchia; Gennaro Ilardi; Mario Acunzo; Giovanni Nigita; Federica Sasdelli; Angela Celetti; Angela Strambi; Stefania Staibano; Carlo Maria Croce; Mario Chiariello
Journal:  Oncotarget       Date:  2016-04-12

Review 6.  Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells-Relevance for Understanding (Germ Cell) Tumorigenesis.

Authors:  Dennis M Timmerman; Tessa L Remmers; Sanne Hillenius; Leendert H J Looijenga
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

7.  Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer.

Authors:  F Selle; J Gligorov; S Richard; A Khalil; I Alexandre; D Avenin; S Provent; D G Soares; J P Lotz
Journal:  Braz J Med Biol Res       Date:  2014-11-04       Impact factor: 2.590

Review 8.  Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review.

Authors:  Francesco Jacopo Romano; Sabrina Rossetti; Vincenza Conteduca; Giuseppe Schepisi; Carla Cavaliere; Rossella Di Franco; Elvira La Mantia; Luigi Castaldo; Flavia Nocerino; Gianluca Ametrano; Francesca Cappuccio; Gabriella Malzone; Micaela Montanari; Daniela Vanacore; Vincenzo Quagliariello; Raffaele Piscitelli; Maria Filomena Pepe; Massimiliano Berretta; Carmine D'Aniello; Sisto Perdonà; Paolo Muto; Gerardo Botti; Gennaro Ciliberto; Bianca Maria Veneziani; Francesco De Falco; Piera Maiolino; Michele Caraglia; Maurizio Montella; Ugo De Giorgi; Gaetano Facchini
Journal:  Oncotarget       Date:  2016-12-20

9.  TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia.

Authors:  Keiichi Akizuki; Masaaki Sekine; Yasunori Kogure; Takuro Kameda; Kotaro Shide; Junji Koya; Ayako Kamiunten; Yoko Kubuki; Yuki Tahira; Tomonori Hidaka; Takumi Kiwaki; Hiroyuki Tanaka; Yuichiro Sato; Hiroaki Kataoka; Keisuke Kataoka; Kazuya Shimoda
Journal:  BMC Cancer       Date:  2020-01-02       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.